Report Detail

Pharma & Healthcare Global (United States, European Union and China) Tyrosine Protein Kinase JAK1 Market Research Report 2019-2025

  • RnM3368667
  • |
  • 14 July, 2020
  • |
  • Global
  • |
  • 147 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Tyrosine Protein Kinase JAK1 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tyrosine Protein Kinase JAK1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Tyrosine Protein Kinase JAK1 market is segmented into
AZD-4205
Baricitinib
Cerdulatinib
CJ-15314
Others

Segment by Application, the Tyrosine Protein Kinase JAK1 market is segmented into
Cutaneous Lupus Erythematosus
Eosinophilia
Hairy Cell Leukemia
Others

Regional and Country-level Analysis
The Tyrosine Protein Kinase JAK1 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Tyrosine Protein Kinase JAK1 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tyrosine Protein Kinase JAK1 Market Share Analysis
Tyrosine Protein Kinase JAK1 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tyrosine Protein Kinase JAK1 business, the date to enter into the Tyrosine Protein Kinase JAK1 market, Tyrosine Protein Kinase JAK1 product introduction, recent developments, etc.

The major vendors covered:
AbbVie Inc
Aclaris Therapeutics Inc
Astellas Pharma Inc
AstraZeneca Plc
Bristol-Myers Squibb Co
Chipscreen Biosciences Ltd
CJ HealthCare Corp
Concert Pharmaceuticals Inc
Eli Lilly and Co
Galapagos NV
Incyte Corp
Japan Tobacco Inc
Jiangsu Hengrui Medicine Co Ltd
Nissan Chemical Industries Ltd
Pfizer Inc
Portola Pharmaceuticals Inc
Sareum Holdings Plc
Theravance Biopharma Inc
Vectura Group Plc


1 Study Coverage

  • 1.1 Tyrosine Protein Kinase JAK1 Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Tyrosine Protein Kinase JAK1 Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Tyrosine Protein Kinase JAK1 Market Size Growth Rate by Type
    • 1.4.2 AZD-4205
    • 1.4.3 Baricitinib
    • 1.4.4 Cerdulatinib
    • 1.4.5 CJ-15314
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Tyrosine Protein Kinase JAK1 Market Size Growth Rate by Application
    • 1.5.2 Cutaneous Lupus Erythematosus
    • 1.5.3 Eosinophilia
    • 1.5.4 Hairy Cell Leukemia
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Tyrosine Protein Kinase JAK1 Market Size, Estimates and Forecasts
    • 2.1.1 Global Tyrosine Protein Kinase JAK1 Revenue 2015-2026
    • 2.1.2 Global Tyrosine Protein Kinase JAK1 Sales 2015-2026
  • 2.2 Global Tyrosine Protein Kinase JAK1, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Tyrosine Protein Kinase JAK1 Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Tyrosine Protein Kinase JAK1 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Tyrosine Protein Kinase JAK1 Competitor Landscape by Players

  • 3.1 Tyrosine Protein Kinase JAK1 Sales by Manufacturers
    • 3.1.1 Tyrosine Protein Kinase JAK1 Sales by Manufacturers (2015-2020)
    • 3.1.2 Tyrosine Protein Kinase JAK1 Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Tyrosine Protein Kinase JAK1 Revenue by Manufacturers
    • 3.2.1 Tyrosine Protein Kinase JAK1 Revenue by Manufacturers (2015-2020)
    • 3.2.2 Tyrosine Protein Kinase JAK1 Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Tyrosine Protein Kinase JAK1 Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Tyrosine Protein Kinase JAK1 Revenue in 2019
    • 3.2.5 Global Tyrosine Protein Kinase JAK1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Tyrosine Protein Kinase JAK1 Price by Manufacturers
  • 3.4 Tyrosine Protein Kinase JAK1 Manufacturing Base Distribution, Product Types
    • 3.4.1 Tyrosine Protein Kinase JAK1 Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Tyrosine Protein Kinase JAK1 Product Type
    • 3.4.3 Date of International Manufacturers Enter into Tyrosine Protein Kinase JAK1 Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Tyrosine Protein Kinase JAK1 Market Size by Type (2015-2020)
    • 4.1.1 Global Tyrosine Protein Kinase JAK1 Sales by Type (2015-2020)
    • 4.1.2 Global Tyrosine Protein Kinase JAK1 Revenue by Type (2015-2020)
    • 4.1.3 Tyrosine Protein Kinase JAK1 Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Tyrosine Protein Kinase JAK1 Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Tyrosine Protein Kinase JAK1 Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Tyrosine Protein Kinase JAK1 Revenue Forecast by Type (2021-2026)
    • 4.2.3 Tyrosine Protein Kinase JAK1 Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Tyrosine Protein Kinase JAK1 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Tyrosine Protein Kinase JAK1 Market Size by Application (2015-2020)
    • 5.1.1 Global Tyrosine Protein Kinase JAK1 Sales by Application (2015-2020)
    • 5.1.2 Global Tyrosine Protein Kinase JAK1 Revenue by Application (2015-2020)
    • 5.1.3 Tyrosine Protein Kinase JAK1 Price by Application (2015-2020)
  • 5.2 Tyrosine Protein Kinase JAK1 Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Tyrosine Protein Kinase JAK1 Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Tyrosine Protein Kinase JAK1 Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Tyrosine Protein Kinase JAK1 Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Tyrosine Protein Kinase JAK1 by Country
    • 6.1.1 North America Tyrosine Protein Kinase JAK1 Sales by Country
    • 6.1.2 North America Tyrosine Protein Kinase JAK1 Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Tyrosine Protein Kinase JAK1 Market Facts & Figures by Type
  • 6.3 North America Tyrosine Protein Kinase JAK1 Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Tyrosine Protein Kinase JAK1 by Country
    • 7.1.1 Europe Tyrosine Protein Kinase JAK1 Sales by Country
    • 7.1.2 Europe Tyrosine Protein Kinase JAK1 Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Tyrosine Protein Kinase JAK1 Market Facts & Figures by Type
  • 7.3 Europe Tyrosine Protein Kinase JAK1 Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Tyrosine Protein Kinase JAK1 by Region
    • 8.1.1 Asia Pacific Tyrosine Protein Kinase JAK1 Sales by Region
    • 8.1.2 Asia Pacific Tyrosine Protein Kinase JAK1 Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Tyrosine Protein Kinase JAK1 Market Facts & Figures by Type
  • 8.3 Asia Pacific Tyrosine Protein Kinase JAK1 Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Tyrosine Protein Kinase JAK1 by Country
    • 9.1.1 Latin America Tyrosine Protein Kinase JAK1 Sales by Country
    • 9.1.2 Latin America Tyrosine Protein Kinase JAK1 Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Tyrosine Protein Kinase JAK1 Market Facts & Figures by Type
  • 9.3 Central & South America Tyrosine Protein Kinase JAK1 Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Tyrosine Protein Kinase JAK1 by Country
    • 10.1.1 Middle East and Africa Tyrosine Protein Kinase JAK1 Sales by Country
    • 10.1.2 Middle East and Africa Tyrosine Protein Kinase JAK1 Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Tyrosine Protein Kinase JAK1 Market Facts & Figures by Type
  • 10.3 Middle East and Africa Tyrosine Protein Kinase JAK1 Market Facts & Figures by Application

11 Company Profiles

  • 11.1 AbbVie Inc
    • 11.1.1 AbbVie Inc Corporation Information
    • 11.1.2 AbbVie Inc Description and Business Overview
    • 11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AbbVie Inc Tyrosine Protein Kinase JAK1 Products Offered
    • 11.1.5 AbbVie Inc Related Developments
  • 11.2 Aclaris Therapeutics Inc
    • 11.2.1 Aclaris Therapeutics Inc Corporation Information
    • 11.2.2 Aclaris Therapeutics Inc Description and Business Overview
    • 11.2.3 Aclaris Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Products Offered
    • 11.2.5 Aclaris Therapeutics Inc Related Developments
  • 11.3 Astellas Pharma Inc
    • 11.3.1 Astellas Pharma Inc Corporation Information
    • 11.3.2 Astellas Pharma Inc Description and Business Overview
    • 11.3.3 Astellas Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Products Offered
    • 11.3.5 Astellas Pharma Inc Related Developments
  • 11.4 AstraZeneca Plc
    • 11.4.1 AstraZeneca Plc Corporation Information
    • 11.4.2 AstraZeneca Plc Description and Business Overview
    • 11.4.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 AstraZeneca Plc Tyrosine Protein Kinase JAK1 Products Offered
    • 11.4.5 AstraZeneca Plc Related Developments
  • 11.5 Bristol-Myers Squibb Co
    • 11.5.1 Bristol-Myers Squibb Co Corporation Information
    • 11.5.2 Bristol-Myers Squibb Co Description and Business Overview
    • 11.5.3 Bristol-Myers Squibb Co Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Products Offered
    • 11.5.5 Bristol-Myers Squibb Co Related Developments
  • 11.6 Chipscreen Biosciences Ltd
    • 11.6.1 Chipscreen Biosciences Ltd Corporation Information
    • 11.6.2 Chipscreen Biosciences Ltd Description and Business Overview
    • 11.6.3 Chipscreen Biosciences Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Products Offered
    • 11.6.5 Chipscreen Biosciences Ltd Related Developments
  • 11.7 CJ HealthCare Corp
    • 11.7.1 CJ HealthCare Corp Corporation Information
    • 11.7.2 CJ HealthCare Corp Description and Business Overview
    • 11.7.3 CJ HealthCare Corp Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Products Offered
    • 11.7.5 CJ HealthCare Corp Related Developments
  • 11.8 Concert Pharmaceuticals Inc
    • 11.8.1 Concert Pharmaceuticals Inc Corporation Information
    • 11.8.2 Concert Pharmaceuticals Inc Description and Business Overview
    • 11.8.3 Concert Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Products Offered
    • 11.8.5 Concert Pharmaceuticals Inc Related Developments
  • 11.9 Eli Lilly and Co
    • 11.9.1 Eli Lilly and Co Corporation Information
    • 11.9.2 Eli Lilly and Co Description and Business Overview
    • 11.9.3 Eli Lilly and Co Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Eli Lilly and Co Tyrosine Protein Kinase JAK1 Products Offered
    • 11.9.5 Eli Lilly and Co Related Developments
  • 11.10 Galapagos NV
    • 11.10.1 Galapagos NV Corporation Information
    • 11.10.2 Galapagos NV Description and Business Overview
    • 11.10.3 Galapagos NV Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Galapagos NV Tyrosine Protein Kinase JAK1 Products Offered
    • 11.10.5 Galapagos NV Related Developments
  • 11.1 AbbVie Inc
    • 11.1.1 AbbVie Inc Corporation Information
    • 11.1.2 AbbVie Inc Description and Business Overview
    • 11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AbbVie Inc Tyrosine Protein Kinase JAK1 Products Offered
    • 11.1.5 AbbVie Inc Related Developments
  • 11.12 Japan Tobacco Inc
    • 11.12.1 Japan Tobacco Inc Corporation Information
    • 11.12.2 Japan Tobacco Inc Description and Business Overview
    • 11.12.3 Japan Tobacco Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Japan Tobacco Inc Products Offered
    • 11.12.5 Japan Tobacco Inc Related Developments
  • 11.13 Jiangsu Hengrui Medicine Co Ltd
    • 11.13.1 Jiangsu Hengrui Medicine Co Ltd Corporation Information
    • 11.13.2 Jiangsu Hengrui Medicine Co Ltd Description and Business Overview
    • 11.13.3 Jiangsu Hengrui Medicine Co Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Jiangsu Hengrui Medicine Co Ltd Products Offered
    • 11.13.5 Jiangsu Hengrui Medicine Co Ltd Related Developments
  • 11.14 Nissan Chemical Industries Ltd
    • 11.14.1 Nissan Chemical Industries Ltd Corporation Information
    • 11.14.2 Nissan Chemical Industries Ltd Description and Business Overview
    • 11.14.3 Nissan Chemical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Nissan Chemical Industries Ltd Products Offered
    • 11.14.5 Nissan Chemical Industries Ltd Related Developments
  • 11.15 Pfizer Inc
    • 11.15.1 Pfizer Inc Corporation Information
    • 11.15.2 Pfizer Inc Description and Business Overview
    • 11.15.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Pfizer Inc Products Offered
    • 11.15.5 Pfizer Inc Related Developments
  • 11.16 Portola Pharmaceuticals Inc
    • 11.16.1 Portola Pharmaceuticals Inc Corporation Information
    • 11.16.2 Portola Pharmaceuticals Inc Description and Business Overview
    • 11.16.3 Portola Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Portola Pharmaceuticals Inc Products Offered
    • 11.16.5 Portola Pharmaceuticals Inc Related Developments
  • 11.17 Sareum Holdings Plc
    • 11.17.1 Sareum Holdings Plc Corporation Information
    • 11.17.2 Sareum Holdings Plc Description and Business Overview
    • 11.17.3 Sareum Holdings Plc Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Sareum Holdings Plc Products Offered
    • 11.17.5 Sareum Holdings Plc Related Developments
  • 11.18 Theravance Biopharma Inc
    • 11.18.1 Theravance Biopharma Inc Corporation Information
    • 11.18.2 Theravance Biopharma Inc Description and Business Overview
    • 11.18.3 Theravance Biopharma Inc Sales, Revenue and Gross Margin (2015-2020)
    • 11.18.4 Theravance Biopharma Inc Products Offered
    • 11.18.5 Theravance Biopharma Inc Related Developments
  • 11.19 Vectura Group Plc
    • 11.19.1 Vectura Group Plc Corporation Information
    • 11.19.2 Vectura Group Plc Description and Business Overview
    • 11.19.3 Vectura Group Plc Sales, Revenue and Gross Margin (2015-2020)
    • 11.19.4 Vectura Group Plc Products Offered
    • 11.19.5 Vectura Group Plc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Tyrosine Protein Kinase JAK1 Market Estimates and Projections by Region
    • 12.1.1 Global Tyrosine Protein Kinase JAK1 Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Tyrosine Protein Kinase JAK1 Revenue Forecast by Regions 2021-2026
  • 12.2 North America Tyrosine Protein Kinase JAK1 Market Size Forecast (2021-2026)
    • 12.2.1 North America: Tyrosine Protein Kinase JAK1 Sales Forecast (2021-2026)
    • 12.2.2 North America: Tyrosine Protein Kinase JAK1 Revenue Forecast (2021-2026)
    • 12.2.3 North America: Tyrosine Protein Kinase JAK1 Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Tyrosine Protein Kinase JAK1 Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Tyrosine Protein Kinase JAK1 Sales Forecast (2021-2026)
    • 12.3.2 Europe: Tyrosine Protein Kinase JAK1 Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Tyrosine Protein Kinase JAK1 Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Tyrosine Protein Kinase JAK1 Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Tyrosine Protein Kinase JAK1 Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Tyrosine Protein Kinase JAK1 Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Tyrosine Protein Kinase JAK1 Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Tyrosine Protein Kinase JAK1 Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Tyrosine Protein Kinase JAK1 Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Tyrosine Protein Kinase JAK1 Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Tyrosine Protein Kinase JAK1 Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Tyrosine Protein Kinase JAK1 Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Tyrosine Protein Kinase JAK1 Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Tyrosine Protein Kinase JAK1 Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Tyrosine Protein Kinase JAK1 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Tyrosine Protein Kinase JAK1 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Tyrosine Protein Kinase JAK1 Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Tyrosine Protein Kinase JAK1. Industry analysis & Market Report on Tyrosine Protein Kinase JAK1 is a syndicated market report, published as Global (United States, European Union and China) Tyrosine Protein Kinase JAK1 Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Tyrosine Protein Kinase JAK1 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,084.90
    4,627.35
    6,169.80
    3,595.80
    5,393.70
    7,191.60
    605,670.00
    908,505.00
    1,211,340.00
    325,650.00
    488,475.00
    651,300.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report